Catalyst Wire Dossier Catalyst Wire Dossier

edaravone dexborneol sequential therapy

edaravone dexborneol sequential therapy · Simcere Pharmaceutical Co., Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for edaravone dexborneol sequential therapy, covering 2023-12-20 to 2023-12-20. Get the full timeline:

Most recent: Clinical Trial Update: The Efficacy and Safety of Edaravone Dexborneol Sequential Therapy in the Treatment of Patients With AIS [Phase 3]

See pricing